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School of Medicine celebrates 20 years of 
participation in Framingham Heart Study 
The School of Medicine recently celebrated 20 years of Boston 
University's participation in the Framingham Heart Study with a 
commemorative dinner at which three generations of Study 
directors gathered, including the first medical director, Thomas 
R. Dawber, M.D., a retired BUSM professor of medicine and 
public health. William B. Kannel, M.D., M.P.H., who is a 
professor of medicine and who took the reins from Dawber in 
1966, hosted the dinner, which was held on Sept. 28 at the 
Castle on the Charles River Campus. Also attending the dinner 
was William P. Castelli, M.D., an adjunct associate professor of 
medicine and the current director of the Study. 
William Zukel, M.D., former deputy director of the National 
Heart, Lung, and Blood Institute's Division of Heart and Vas-
cular Disease, discussed the role of Boston University in the his-
tory of the Study. Dean Emeritus John Sandson, M.D., also 
spoke at the event. 
Dawber recounted how he became involved in the Framing-
ham Heart Study and how the Study has affected the medical 
community. The Study, said Dawber, has had a major impact on 
how the physician views his or her role. Before the Study, the 
responsibilities of the physician lay in detecting, diagnosing and 
treating disease, he said. Now, he said, the physician is just as 
concerned with maintaining the health of the patient. 
Day-long program featured offspring, talks 
The following day, the Section of Preventive Medicine and 
Epidemiology of the School's Department of Medicine 
presented a day-long program at Framingham Union Hospital on 
"Contributions of the Framingham Study to the Conquest of Car-
diovascular Disease." 
Speakers included: David L . Bachman, M.D. , an assistant 
professor of neurology, who spoke on "Prevalence and Types of 
Dementia in the Framingham Community"; Castelli, who spoke 
on the "Framingham Study Perspective on the Status of the Diet-
Heart Hypothesis"; George Cytroen, M.D. , an assistant clinical 
professor of medicine, Lawrence M . Epstein, M.D. , an assis-
tant clinical professor of medicine, and Donald E. Love, M.D. , 
an assistant professor of medicine, all of whom spoke on 
"Reflections of the Framingham Physicians on the Framingham 
Study"; Kannel, who spoke on "Contributions of the Framing-
ham Study to the Understanding of Coronary Risk Factors"; 
Carlos S. Kase, M.D. , an associate professor of neurology and 
pathology, who spoke on "Post-Stroke Disability in the Framing-
ham Cohort"; Joseph Stokes I I I , M.D. , a professor of medicine 
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FRAMINGHAM STUDY DINNER SPEAKERS—Those who 
spoke during the Framingham Heart Study commemorative dinner 
were, from left to right, William B. Kannel, M.D., M.P.H., Thomas 
R. Dawber, M.D., Dean Emeritus John I. Sandson, M.D., and 
William Zukel, M.D., former deputy director of the National Heart, 
Lung, and Blood Institute s Division of Heart and Vascular Dis-
ease. (Photo by Gustav Freedman) 
and public health (epidemiology and biostatistics), who 
presented welcoming remarks and who, along with Kannel, coor-
dinated the program; and Philip A. Wolf, M.D., a professor of 
neurology and principal investigator of the Framingham Stroke 
Study, who spoke on "Framingham's Contribution to Risk Fac-
tors for Stroke." An afternoon program followed for Framing-
ham Study offspring and their family members at which Castelli 
and Daniel Levy, M.D. , an assistant professor of medicine, dis-
cussed Study findings. 
BUSM and B C H researchers to test 
new drug for treatment of AIDS 
Researchers at the School of Medicine and Boston City Hospital 
are involved in a new drug trial to determine the safety and ef-
ficacy of dideoxyinosine (ddl) in the treatment of patients with 
AIDS or AIDS-related complex. Ddl is a member of the same 
chemical group as AZT, which currently is the only approved 
treatment for AIDS. Ddl works in the same manner as AZT: it 
inhibits an enzyme necessary for the replication of the HIV virus. 
Between 20 and 40 patients wi l l participate in the initial study 
at BCH. Patients wiU be hospitalized for 16 days while they 
receive ddl intravenously and subsequently wi l l be given the 
drug orally for four additional weeks on an outpatient basis. It is 
hoped that ddl wi l l be as effective as AZT without some of 
AZT's side effects. The side effects, which can be serious 
enough that patients require blood transfusions and a reduction 
in dosage, may include anemia, suppression of white blood 
count and headaches. 
Howard Liebman, M.D., an assistant professor of medicine at 
BUSM and medical director of the Clincal AIDS Service at 
BCH, is principal investigator of the study. Timothy Cooley, 
M.D., an assistant professor of medicine at BUSM and a mem-
ber of the Clinical AIDS Service, is co-investigator. Ronald 
McCaffrey, M.D., a professor of medicine at BUSM, wi l l 
provide laboratory support for the study. 
International conference on impotence 
attracts specialists from 28 countries 
The School of Medicine recently hosted the International 
Society for Impotence Research meeting, which was the largest 
conference of its kind ever held, according to Irwin Goldstein, 
M.D., an associate professor of urology and coordinator of the 
New England Male Reproductive Center at the University Hospi-
tal. In addition, the conference featured the first international 
symposium on female sexual dysfunction. The conference, 
which highlighted new findings concerning the diagnosis and 
treatment of impotence, took place in Boston and attracted more 
than 35frspecialists from 28 countries. 
More than 200 papers were presented at the meeting, many of 
them dealing with new findings. Researchers at BUSM are inter-
nationally known for their work in impotence and the School 
houses one of the largest National Institutes of Health-funded re-
search laboratories for impotence. 
Speakers at the conference from BUSM included: Irwin 
Goldstein, M.D., and Robert J. Krane, M.D., chairman of the 
BUSM Department of Urology, chief of urology at U H and co-
director of the New England Male Reproductive Center at UH, 
both of whom also were moderators; Mike B. Siroky, M.D., an 
associate professor of urology; and Herbert H. Wotiz, Ph.D., a 
professor of biochemistry, a research professor of urology and 
director of BUSM's Humphrey Cancer Research Center. 
Nobel laureate, faculty report on latest 
Alzbeimer's researeb at VA conference 
The School of Medicine and the Geriatric Research, Evaluation 
and Care Center (GRECC) at the Edith Nourse Rogers 
Memorial Veterans Hospital recently co-sponsored a symposium 
on "Advances in Alzheimer's Research" at which a Nobel 
laureate and several BUSM faculty members spoke. 
Keynote speaker Carleton Gajdusek, M.D., chief of the 
Laboratory of Central Nervous System Studies at the National 
Institute of Neurological Communicative Disorders and Stroke 
in Bethesda, Md., in 1977 was awarded the Nobel Prize in 
physiology and medicine. Gajdusek, who is noted for his dis-
coveries of slow virus infections as a result of his field work on 
kuru, a chronic degenerative slow virus disease of the central 
nervous system, spoke on "Transmissable and Nontransmissable 
Amyloidosis of the Brain: Slow Virus Dementias, Normal 
Aging and Alzheimer's Disease." 
Other speakers and their topics included: Richard E . Fine, 
Ph.D., a professor of biochemistry and director of GRECC, and 
Michael Kane, director of the Edith Nourse Rogers Memorial 
Veterans Hospital, both of whom presented welcoming remarks; 
Gerhard Heinrich, M.D., an assistant professor of medicine 
and neuroscience, who spoke on "Molecular Genetics of Human 
Nerve Growth Factor: Possible Role in the Treatment of 
Alzheimer's Disease"; Thomas Kemper, M.D., a professor of 
neurology, who spoke on "New Thoughts on the Neuropathy of 
Alzheimer's Disease"; Mark Moss, Ph.D., an assistant profes-
sor of anatomy and neurology, who spoke on "Role of the Basal 
Forebrain and Hippocampus in Alzheimer's Disease"; Richard 
Myers, Ph.D., an associate professor of neurology, who spoke 
on "Assessment of Genetic Risk for Alzheimer's Disease 
Among First Degree Relatives"; Miriam Schweber, Ph.D., an 
assistant professor of biochemistry, who spoke on "Chromosome 
21 DNA Levels in Alzheimer's Disease"; and Ladislav Volicer, 
M.D., Ph.D., a professor of pharmacology and psychiatry, assis-
tant professor of medicine and deputy director of GRECC, who 
spoke on "Endogenous Neurotoxin as a Cause of Alzheimer's 
Disease: Implications for Treatment Strategies." 
BUSM researcbers take part in study 
tbat tests pbotopberesis tberapy 
Howard Koh, M.D., an assistant professor of dermatology, 
medicine and public health at BUSM, and researchers at the 
School are taking part in a multi-center study that began this 
October to determine the effectiveness of photopheresis in treat-
ing chronic lymphocytic leukemia, one of the four major types 
of leukemia. Photopheresis is a new form of therapy that uses a 
drug activated by ultraviolet light to halt the replication of cer-
tain cancer cells. 
Patients in the study wi l l receive photopheresis therapy once 
every three weeks. Koh now uses the therapy to treat patients 
with Sezary's syndrome, a severe type of skin cancer. Sezary's 
syndrome causes extreme redness and scaling of the skin and 
can spread into the bloodstream, causing a form of leukemia. 
According to Koh, who also is a dermatologist and oncologist 
at the University Hospital, i t is not clear how the process works. 
However, photopheresis not only prevents cancer cells from 
replicating, but also appears to stimulate the body's immune 
response against the malignant cells. The University Hospital is 
the only institution in northern New England and one of only 12 
institutions in the country offering photopheresis therapy. 
SPH Healtb Law Section sponsors 
montbly Faculty Seminars on AIDS 
The Health Law Section of the School of Public Health is spon-
soring the Faculty Seminar on AIDS, a monthly brown-bag 
luncheon at which members of the BUSM and SPH faculty have 
an opportunity to learn about their colleagues' AIDS research. 
The meetings wi l l be held from noon to 1 p.m. on the last Friday 
3 
of each month in Conference Room C-D on the second floor of 
the Atrium Pavilion. 
The dates of the Seminar, which may vary because of 
holidays, are as follows: Wednesday, Nov. 9; Friday, Dec. 16; 
Friday, Jan. 27,1989; Friday, Feb. 24; Friday, March 31; Friday, 
April 28; and Friday, May 26. For more information, please call 
coordinator Wendy K. Mhriner, J.D., L L . M . , M.P.H., an as-
sociate professor of health law, at x4626 (638-4626). 
BUSM granted accreditation 
for training program in medical genetics 
The newly established training program in medical genetics 
recently received a five-year accreditation by the American 
Board of Medical Genetics, according to Aubrey Milunsky, 
MB.B.Ch., D.Sc, F.R.C.P., D.C.H. Milunsky is director of 
BUSM's Center for Human Genetics and a professor of 
pediatrics, obstetrics and gynecology, and pathology. 
The accreditation was approved for the following areas: 
M.D. clinical genetics, Ph.D. medical genetics, and clinical 
cytogenetics. The program allows individuals to receive formal 
training so that they may become board certified in the three 
areas. 
AID FOR CANCER RESEARCH DONATION—Richard Neiman. 
M.D., far left, was among cancer researchers at the Mallory who 
recently received new equipment donated by Aid for Cancer 
Research. Shown here with Neiman are hematopathology fellow 
George Wade, M.D., Ph.D., center, and Florence Litchman, chair-
woman of the ACR presentation committee. A tour of the labs and a 
reception recently was held to express appreciation to the group. 
(Photo by David Keough, BUSM Educational Media Support Center) 
New book by Joel Herskowitz, M.D., 
examines cbildbood depression 
"Is Your Child Depressed?" (Pharos Books, New York, 1988) is 
a new book by Joel Herskowitz, M.D., an assistant clinical 
professor of pediatrics at the School. The book gives parents in-
sight on recognizing and deahng with depression in their 
children, ages 4 to 19. 
According to Herskowitz, the symptoms of depression in 
children often differ from depression in adults. A depressed 
child is more likely to be tired, irritable and angry. The child's 
schoolwork may suffer and he or she may gain or lose a sig-
nificant amount of weight or experience frequent headaches or 
stomachaches. 
New book by Wolf, Neiman 
looks at disorders of tbe spleen 
Barbara C. Wolf, M.D., an assistant professor of pathology, and 
Richard S. Neiman, M.D., a professor of pathology and chief of 
the Hematopathology Section of the Mallory Institute of Pathol-
ogy, recently co-authored "Disorders of the Spleen," (W.B. 
Saunders, Philadelphia, 1988) a sourcebook that explores the 
anatomy, physiology and pathophysiology of the spleen. 
The book covers such topics as functions of the spleen, dif-
ferential diagnosis of diseases involving the organ, the latest in 
spleen-related immunology, Hodgkin's disease, leukemias and 
hyper- and hyposplenism. The text is supplemented by 
photomicrographs and color plates. 
Aid for Cancer Researeb donates funds 
for new equipment at tbe Mallory 
Aid for Cancer Research, a group of volunteers who raise money 
for cancer research, recently provided funds for the purchase of 
three new pieces of equipment for BUSM cancer researchers at 
the Mallory Institute of Pathology. 
Richard Neiman, M.D., a professor of pathology and chief of 
the Hematopathology Section of the Mallory, received a Probe-
Tek Automated Southern Blot Analyzer, which detects 
molecular changes in cancer cells before they can be detected by 
routine immunologic or microscopic methods. Michael 
O'Brien, M.D., a professor of pathology and associate director 
of the Mallory, received a Cyto-tek Cytocentrifuge and a Histos-
tat Cryostat Microtome for sectioning live tissue. 
Boston University begins United Way 
campaign; goal set at $125,000 
The annual United Way Campaign was kicked off at Boston 
University on Oct. 5. The goal of this year's campaign, which 
wi l l end Nov. 21, is $125,000. The United Way raises funds for 
hundreds of health and human services agencies. 
From Oct. 21 through Nov. 18, drawings wil l be held each 
Friday for those University employees who have contributed. 
The prizes range from theater tickets to a week-long winter vaca-
tion for two. Pledges may be made by cash, check, monthly 
payroll deductions or direct billing. 
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BUSM student receives award 
for achievement in science, technology 
Richard Browne '91 , a student in the Early Medical School 
Selection Program at BUSM, recently received the second an-
nual White House Initiative Student Award for Outstanding 
Achievement in Science and Technology. The award was given 
by the 1988 White House Initiative on Historically Black Col-
leges and Universities Science and Technology Advisory Com-
mittee. 
Browne, who wi l l complete his senior year of undergraduate 
work at BUSM, wi l l return to the University of the Virgin Is-
lands for graduation next spring. His goal after graduation is to 
work to improve the health-care in the Virgin Islands. The 
award was given to 34 students who were nominated by their 
peers. 
Centerscope wins award for best cover 
The School of Medicine's thrice-yearly magazine, Centerscope, 
recently received an award from Magazine Design & Production 
in the category of best cover for an educational magazine. The 
Fall 1987 issue of Centerscope, one of 1,100 entries from the 
United States and Canada, received the bronze Ozzie Award for 
Design Excellence. The cover, which depicted the cover story 
on epidemiology, was a photo of a ceramic illustration by 
freelance artist Ken Goldstrom. 
Centerscope is produced by the Department of Marketing and 
Public Affairs' Office of Publication Services, Owen J. 
McNamara, director. The Centerscope staff consists of Marjorie 
H. Dwyer, managing editor; Cynthia A. Koury, editor; and 
Harry Breger, of the Boston University Graphic Design Office, 
designer. Donald R. Giller is director of Marketing and Public 
Affairs. 
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